High prevalence of lower limb atherosclerosis is linked with the gut-liver axis in patients with primary biliary cholangitis

被引:12
作者
Ponziani, Francesca Romana [1 ,2 ]
Nesci, Antonio [3 ]
Caputo, Camilla [1 ]
Salvatore, Lucia [1 ]
Picca, Anna [4 ,5 ]
Del Chierico, Federica [6 ]
Sterbini, Francesco Paroni [7 ]
Marzetti, Emanuele [4 ]
Di Giorgio, Angela [3 ]
Santoro, Luca [3 ]
Putignani, Lorenza [6 ,8 ]
Gasbarrini, Antonio [1 ,2 ]
Santoliquido, Angelo [2 ,3 ]
Pompili, Maurizio [1 ,2 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Internal Med & Gastroenterol Hepatol Unit, I-00168 Rome, Italy
[2] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Cardiovasc Sci, Angiol & Noninvas Vasc Diagnost Unit, Rome, Italy
[3] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Geriatr Neurosci & Orthoped, Rome, Italy
[4] Bambino Gesu Childrens Hosp IRCCS, Unit Human Microbiome, Multimodal Lab Med Res Area, Rome, Italy
[5] LUM Univ, Dept Med & Surg, Casamassima, Italy
[6] Fdn Policlin Univ Agostino Gemelli IRCCS, Phase Unit 1, Rome, Italy
[7] Bambino Gesu Pediat Hosp, Dept Diagnost & Lab Med, Unit Microbiol & Diagnost Immunol,Lab Med Res Are, Unit Human Microbiome,Unit Microbi & Multimodal, Rome, Italy
[8] Catholic Univ, Rome, Italy
关键词
atherosclerosis; gut microbiota; inflammation; NAFLD; PBC; CARDIOVASCULAR RISK; HYPERLIPIDEMIA; EXPRESSION; CIRRHOSIS; DISEASE;
D O I
10.1111/liv.15463
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Hypercholesterolemia is frequent in people with primary biliary cholangitis (PBC); however, it does not seem to confer an increased risk of cardiovascular disease. We aimed to evaluate the prevalence of peripheral arterial disease in PBC women and its association with the gut-liver axis and systemic inflammation. Methods Thirty patients affected by PBC and hypercholesterolemia were enrolled, with equal-sized groups of women with non-alcoholic fatty liver disease (NAFLD) and healthy controls (CTRL). All patients underwent Doppler ultrasound examination of peripheral arteries, assessment of flow-mediated dilation, quantification of circulating cytokines and vasoactive mediators and characterization of the gut microbiota. Results PBC patients had a higher prevalence of lower extremity arterial disease (LEAD) defined as atherosclerotic plaques in any of femoral, popliteal and/or tibial arteries compared with both NAFLD and CTRL women (83.3% vs. 53.3% and 50%, respectively; p = .01). Factors associated with LEAD at univariate analysis were VCAM-1 (p = .002), ICAM-1 (p = .003), and TNF-alpha (p = .04) serum levels, but only VCAM-1 (OR 1.1, 95% CI 1.0-1.1; p = .04) and TNF-alpha (OR 1.12, 95% CI 0.99-1.26; p = .04) were confirmed as independent predictors in the multivariate model. Gut microbiota analysis revealed that Acidaminococcus (FDR = 0.0008), Bifidobacterium (FDR = 0.001) and Oscillospira (FDR = 0.03) were differentially expressed among groups. Acidaminococcus, which was increased in PBC, was positively correlated with TNF-alpha serum levels. Down-regulation of metabolic pathways linked to fatty acid and butyrate metabolism, glyoxylate metabolism and branched-chain amino acids degradation was found in the functional gut metagenome of PBC women. Conclusions LEAD is common in patients affected by PBC and is associated with inflammatory markers and alterations in the gut-liver axis.
引用
收藏
页码:370 / 380
页数:11
相关论文
共 41 条
  • [1] Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders
    Agueero, Fernando
    Gonzalez-Zobl, Griselda
    Baena-Diez, Jose M.
    Degano, Irene R.
    Garcia-Gil, Maria
    Teresa Alzamora, Maria
    Marrugat, Jaume
    Comas-Cufi, Marc
    Pera, Guillem
    Elosua, Roberto
    Ramos, Rafel
    Grau, Maria
    [J]. ATHEROSCLEROSIS, 2015, 242 (01) : 1 - 7
  • [2] Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease
    Aryal, Sachin
    Alimadadi, Ahmad
    Manandhar, Ishan
    Joe, Bina
    Cheng, Xi
    [J]. HYPERTENSION, 2020, 76 (05) : 1555 - 1562
  • [3] Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis
    Borchers, Andrea T.
    Shimoda, Shinji
    Bowlus, Christopher
    Keen, Carl L.
    Gershwin, M. Eric
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2009, 31 (03) : 309 - 322
  • [4] Inflammation in Peripheral Artery Disease
    Brevetti, Gregorio
    Giugliano, Giuseppe
    Brevetti, Linda
    Hiatt, William R.
    [J]. CIRCULATION, 2010, 122 (18) : 1862 - 1875
  • [5] Gut Microbiome Alterations in Patients With Carotid Atherosclerosis
    Chen, Jingfeng
    Qin, Qian
    Yan, Su
    Yang, Yang
    Yan, Hang
    Li, Tiantian
    Wang, Lin
    Gao, Xinxin
    Li, Ang
    Ding, Suying
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [6] Butyrate-producing bacteria and the gut-heart axis in atherosclerosis
    Chen, Wujun
    Zhang, Shun
    Wu, Jianfeng
    Ye, Ting
    Wang, Shuai
    Wang, Pan
    Xing, Dongming
    [J]. CLINICA CHIMICA ACTA, 2020, 507 : 236 - 241
  • [7] Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data
    Chong, Jasmine
    Liu, Peng
    Zhou, Guangyan
    Xia, Jianguo
    [J]. NATURE PROTOCOLS, 2020, 15 (03) : 799 - 821
  • [8] Conrad N, 2022, LANCET, V400, P733, DOI 10.1016/S0140-6736(22)01349-6
  • [9] Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
    Cristofori, Fernanda
    Dargenio, Vanessa Nadia
    Dargenio, Costantino
    Miniello, Vito Leonardo
    Barone, Michele
    Francavilla, Ruggiero
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753